Afficher la couverture 'Molecular Targets for the Treatment of Metastatic Colorectal Cancer | Cohen, Romain' en grand format
/5

0 avis

Molecular Targets for the Treatment of Metastatic Colorectal Cancer

Archive ouverte

Cohen, Romain | Pudlarz, Thomas | Delattre, Jean-François | Colle, Raphaël | André, Thierry

Edité par CCSD ; MDPI -

International audience. Over the past years, colorectal cancer (CRC) was subtyped according to its molecular and genetic characteristics, allowing the development of therapeutic strategies, based on predictive biomarkers. Biomarkers such as microsatellite instability (MSI), RAS and BRAF mutations, HER2 amplification or NTRK fusions represent major tools for personalized therapeutic strategies. Moreover, the routine implementation of molecular predictive tests provides new perspectives and challenges for the therapeutic management of CRC patients, such as liquid biopsies and the reintroduction of anti-EGFR monoclonal antibodies. In this review, we summarize the current landscape of targeted therapies for metastatic CRC patients, with a focus on new developments for EGFR blockade and emerging biomarkers (MSI, HER2, NTRK).

Suggestions

Du même auteur

Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer

Archive ouverte | Bui, Quang Loc | CCSD

International audience. Background: Several studies reported improved outcomes with conventional treatments (CT, i.e., chemotherapy ± targeted therapy) administered after immune checkpoints inhibitors (ICI) in certa...

Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency

Archive ouverte | Cohen, Romain | CCSD

International audience. Microsatellite instability (MSI) is a tumor phenotype related to a deficient DNA mismatch repair system (dMMR). This phenotype, observed in 5% of metastatic mCRC but 10–18% of localized CRC, ...

Immune Checkpoint Inhibition in Colorectal Cancer: Microsatellite Instability and Beyond

Archive ouverte | Cohen, Romain | CCSD

International audience. Immune checkpoints inhibitors (ICIs) have been a breakthrough, with unique response and survival patterns compared with chemotherapy for patients with advanced Mismatch Repair-deficient/Micro...

Chargement des enrichissements...